In the former, the KD restored IBS‐induced reductions in crypt length, occludin, glucose transporter protein type 1, and cannabinoid receptor 1 in the distal small intestine, all of which may contribute to its beneficial effects in IBS.[93] Similar protective effects are also observed in colitis. The gene discussed is OCLN; the disease is irritable bowel syndrome.